US Capital Partners Secures $2 Million in Financing Through Asset Sale for Mesa Pharmacy, Inc.
Private investment bank secures strategic financing for California-based pharmaceutical compound manufacturer.
SAN FRANCISCO, SEPTEMBER 2012 – US Capital Partners, LLC has secured $2 million in financing through a successful sale of accounts receivable for Mesa Pharmacy, Inc. (“Mesa Pharmacy”), based in Irvine, CA. US Capital Partners is a private investment bank, direct lender, and lead debt and equity financial participant and arranger that specializes in structuring and providing the best available financing for small to lower middle market companies.
“Mesa Pharmacy needed to retire existing senior debt and locate additional working capital for expansion and market entry,” said Ed Kurtz, Chief Operating Officer at Mesa Pharmacy. “US Capital Partners assisted us in achieving these objectives by successfully securing $2 million in financing for the company through an asset sale.”
“We are delighted to have assisted this growing California pharmacy business,” said Jeffrey Sweeney, CEO and Managing Director at US Capital Partners. “Mesa Pharmacy was locked in an inappropriate financing structure, which was hindering its growth. US Capital Partners successfully arranged $2 million for the company through a sale of its medical receivables within the California workers’ compensation industry. Our innovative and pragmatic underwriting solutions and our in-depth understanding of medical receivables was critical to closing.”
About Mesa Pharmacy, Inc.
Headquartered in Irvine, CA, Mesa Pharmacy provides customized compounds for pain management, bio-identical hormone replacement therapy, and a variety of other applications. Mesa Pharmacy is a wholly owned operating subsidiary of Pharmacy Development Corp., established in 2007 to develop an alternative to typical oral medication for pain management. Working with California-based physicians for industrial pain management, Mesa Pharmacy has successfully formulated prescription-strength topical medication as an alternative to commonly used oral medications.
About US Capital Partners, LLC
Since 1998, US Capital Partners (www.uscapitalpartners.net) has been providing prompt, innovative, and reliable financing solutions including lending, corporate financing, and debt re-structuring to businesses across the United States and abroad. US Capital Partners is a private investment bank that specializes in asset-based debt and equity financing for small to middle market private and public companies. The company’s innovative approach allows it to provide the best financing available, not only for companies in excellent financial condition, but also for companies that may have been refused credit by traditional lenders.
If you would like to know more about how your business can secure the financing it needs, email Jeffrey Sweeney, CEO and Managing Director, at jsweeney@uscapitalpartners.net or call (415) 889-1010.